Bruce Buckingham, MD
Dr. Buckingham received his medical degree from University of California at San Diego. He completed his internship, residency, and fellowship at Children’s Hospital of Los Angeles. He is currently a Professor in the Department of Pediatric Endocrinology at Stanford Medical Center and the Stanford Children’s Hospital. His research focuses on continuous glucose monitoring in children and closed-loop (artificial pancreas) systems. He has collaborated on various overnight and 24-hour closed-loop platforms in development and has helped to develop algorithms for detecting infusion set and sensor failures and to improve infusion set wear duration. Dr.Buckingham is well recognized as a leading expert in the real-world application and clinical use of continuous glucose monitoring systems.
Daniel Einhorn, MD
Dan Einhorn, MD is medical director of the Scripps Whittier Diabetes Institute, clinical professor of medicine (voluntary) at UC San Diego, president of Diabetes and Endocrine Associates, and associate editor of the Journal of Diabetes. He is a trustee and past-president of the American College of Endocrinology (ACE), a founding member and regent of the ACE Foundation, and past-president of the American Association of Clinical Endocrinologists (AACE). He received his BA at Yale (Summa cum Laude), his MD at Tufts (AOA) and his post-graduate training at Harvard. He has been in a leadership position in endocrinology for over 20 years during which time he has had the privilege of co-writing many national guidelines, including those for diabetes, pre-diabetes, inpatient diabetes management, and obesity, as well as leading consensus conferences on insulin resistance, pre-diabetes, obesity, and glucose monitoring. He has won the highest awards from AACE, ACE, and the Endocrine Society as well as numerous other honors. He has been on hundreds of teaching programs, written dozens of papers and chapters on diabetes, served on many dozens of scientific advisory committees, and has participated in clinical research on virtually all classes of diabetes therapies and diagnostics. He continues to be a practicing physician who loves seeing patients and their families and who appreciates the real world education he gets from them every day.
Jon S. Wilensky, MD, FACS
A Board Certified Plastic Surgeon by training, Dr. Jon Wilensky lives and practices in La Jolla/San Diego. A native New Yorker, Dr. Wilensky was born and raised in New York City. He attended The Stuyvesant High School, the premier public science high school in the country, confirming his lifelong desire to be a surgeon. He was 1 of just 9 high school seniors across the nation invited to attend both undergraduate and medical school at the University of Michigan as part of the 7-Year Integrated BS-MD program, directly accepted to the University of Michigan Medical School straight from high school. He completed his MD degree at age 24, matching into the Integrated Plastic Surgery residency program at the University of Michigan Health System, regarded as the foremost 6-year post-MD Plastic Surgery training program in the country. He entered his private practice of Plastic Surgery at age 30 and became the youngest Plastic Surgeon ever certified by the American Board of Plastic Surgery, at age 32. He is now entrenched in the emerging world of implantable biotechnology in the biotech hub of La Jolla/Torrey Pines as the Lead Surgeon for the GlySens FIGS-2 clinical trial. Dr. Wilensky is Assistant Professor of Clinical Plastic Surgery, Endocrinology & Metabolism, and Regenerative Medicine at the UC San Diego Health System.Most recently, Dr. Wilensky was named as recipient of the Emerging Leaders in Biotechnology Fellowship from the UC San Diego Rady School of Management FlexMBA Program. Dr. Wilensky enjoys spending time with his wife and two daughters (ages 8 and 11). An avid outdoorsman, Dr. Wilensky has climbed Mt. Shasta twice, Mt. Rainier, and completed a grueling 24-hour endurance walk across-and- back the Grand Canyon four times.